Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Syros Pharmaceuticals, Inc. has filed 682 SEC EDGAR filings since 22 Aug 2012

SEC filing history

Showing 576-600 of 682 matching filings.

Per page
25
Current page
24
4

FORM 4 -

Filing date
12 Jun 2017
Reporting date
08 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 -

Filing date
12 Jun 2017
Reporting date
08 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37813

8-K

Filing date
12 Jun 2017
Reporting date
08 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-218012

EFFECT filing

Filing date
25 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-218012

424B3

Filing date
25 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
23 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
23 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-218012

S-1

Filing date
15 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37813

8-K

Filing date
26 Apr 2017
Reporting date
26 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-37813

DEF 14A

Filing date
25 Apr 2017
Reporting date
08 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37813

8-K

Filing date
21 Apr 2017
Reporting date
20 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-216821

S-8

Filing date
20 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89552

SC 13G/A filing

Filing date
14 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89552

SC 13G/A filing

Filing date
14 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89552

SYROS PHARMACEUTICALS, INC. -- SCHEDULE 13G/A (AMEND. #1)

Filing date
13 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
13 Feb 2017
Reporting date
10 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
13 Feb 2017
Reporting date
10 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
13 Feb 2017
Reporting date
10 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
13 Feb 2017
Reporting date
10 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
13 Feb 2017
Reporting date
10 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
5

FORM 5 -

Filing date
13 Feb 2017
Reporting date
10 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
30 Jan 2017
Reporting date
27 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
30 Jan 2017
Reporting date
27 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .